Thompson Davis & Co., Inc. Iridex Corp Transaction History
Thompson Davis & Co., Inc.
- $140 Million
- Q2 2025
A detailed history of Thompson Davis & Co., Inc. transactions in Iridex Corp stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 56,726 shares of IRIX stock, worth $62,398. This represents 0.03% of its overall portfolio holdings.
Number of Shares
56,726
Previous 56,726
-0.0%
Holding current value
$62,398
Previous $49,000
-0.0%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding IRIX
# of Institutions
22Shares Held
2.69MCall Options Held
36.1KPut Options Held
0-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$1.1 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA586KShares$644,3940.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny379KShares$416,6360.0% of portfolio
-
Amh Equity LTD190KShares$209,0000.23% of portfolio
-
Geode Capital Management, LLC Boston, MA132KShares$144,9430.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $17.6M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...